Biological properties of cord blood hematopoietic stem cells

QR Code

Biological properties of cord blood hematopoietic stem cells

This article provides an overview of research evolution of umbilical cord blood as a source of hematopoietic stem cells for transplantation. Phased developments of the technology of stem cells detection and selection, their proliferation, differentiation and function assessment using cultivation in...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. A. Rumiantsev, E. Yu. Osipova, S. E. Ipatov, T. V. Shamanskaya, O. A. Mayorova, A. G. Rumyantsev
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Онкогематология
Subjects:	hematopoietic stem cells cord blood cd133+ cells cd34+ cells
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/107
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative characteristics of healthy newborns cord blood cell composition and G-SCF-mobilized blood from healthy donors
by: R. Sh. Ibragimov, et al.
Published: (2022-11-01)

Cell Composition of Cord Blood and G-Scf-Mobilized Blood Transplantational Material
by: R. Sh. Ibragimov, et al.
Published: (2010-06-01)

Influence of an Ante- and Intranatal Factors on Cord Blood Cell Composition of Fullterm Newborns
by: S. A. Roumiantsev, et al.
Published: (2010-06-01)

Equivalents of the neutrophil-to-lymphocyte ratio of circulating pool of stem and immature hematopoietic cells for assessing liver transplant status
by: A. N. Shutko, et al.
Published: (2023-09-01)

Subpopulations of mobilized hematopoietic stem cells in patients with hematological malignances and donors: expression of CD38, HLA-DR and CD143
by: M. L. Kanaeva, et al.
Published: (2019-07-01)

Evaluation of cd44 and Pd-L1 expression during co-cultivation of tumor and hematopoietic stem cells
by: M. V. Bykova, et al.
Published: (2025-03-01)

Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer
by: Sara Huerta-Yepez, et al.
Published: (2025-07-01)

FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)

MOBILIZATION OF STEM CELLS AFTER LIVER TRANSPLANTATION AND RESECTION
by: R. M. Kurabekova, et al.
Published: (2010-06-01)

FEATURES OF CD34+ CELL KINETICS IN CHILDREN WITH DIFFERENT KINDS OF INFLAMMATION
by: I. I. Dolgushin, et al.
Published: (2014-07-01)

Generation of Novel Monoclonal Antibodies Recognizing Rabbit CD34 Antigen
by: Jaromír Vašíček, et al.
Published: (2025-07-01)

Neurological disorders in patients with long COVID syndrome and cell therapy methods for their correction a literature review
by: I. S. Dolgopolov, et al.
Published: (2021-12-01)

Shorter donor leukocyte telomere length is associated with poor peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor
by: Shang-Hsien Yang, et al.
Published: (2025-07-01)

LONG TERM CLINICAL RESULTS OF AUTOLOGOUS CD133+ BONE MARROW CELLS TRANSPLANTATION IN ST ELEVATION MYOCARDIAL INFARCTION PATIENTS
by: M. A. Kirgizova, et al.
Published: (2016-03-01)

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 1. Clinical aspects
by: O. B. Ovsyannikova, et al.
Published: (2020-11-01)

Early markers of induced pluripotent stem cell hematopoietic development
by: O. N. Sheveleva, et al.
Published: (2024-09-01)

Umbilical cord bloods hematopoietic stem cells ex vivo expansion (the literature review)
by: T. V. Shamanskaya, et al.
Published: (2014-07-01)

Mobilization, Isolation and Characterization of Stem Cells from Peripheral Blood: a Systematic Review
by: Natali Yosupov, et al.
Published: (2017-03-01)

CLINICAL EFFECTS OF MESENCHYMAL STROMAL CELLS IN LYMPHOMA PATIENTS WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: E. V. Batorov, et al.
Published: (2012-05-01)

Features of transfusion therapy in hematopoietic stem cell transplantation
by: M. A. Kucher, et al.
Published: (2016-12-01)

Cryostorage of peripheral blood hematopoietic stem cells in transplantology: current status and prospects
by: O. I. Kit, et al.
Published: (2023-12-01)

Factors associated with the number of CD34-positive hematopoietic progenitor cells in the leukocyte concentrate in patients with lymphomas and acute T-lymphoblastic leukemia
by: I. V. Galtseva, et al.
Published: (2024-12-01)

Results of allogeneic hematopoietic stem cell transplantation in a patient with classical Hodgkin's lymphoma
by: A. Р. Strelnikova, et al.
Published: (2021-05-01)

Features of the leukocyte pool of umbilical cell blood cell concentrate prepared for long-term cryostorage
by: O. V. Tyumina, et al.
Published: (2024-04-01)

Umbilical cord and cord blood cells promising for biobanking
by: V. V. Chrishtop, et al.
Published: (2025-05-01)

EVALUATION OF QUALITATIVE AND QUANTITATIVE INDICATORS OF SUBSTITUTIONARY TRANSFUSION THERAPY IN DIFFERENT TYPES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: M. A. Kucher, et al.
Published: (2017-03-01)

ROLE OF MACROPHAGES IN REGULATION OF HEMATOPOIETIC STEM CELL MIGRATION IN BONE MARROW PERIPHERAL BLOOD SYSTEM
by: B. G. Yushkov, et al.
Published: (2014-07-01)

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

IMMUNOMODULATORY EFFECT OF CIRCULATING BONE MARROW PROGENITORS AS A POSSIBLE MECHANISM OF NEUROPROTECTION IN TRAUMATIC BRAIN INJURY
by: V. A. Chernykh, et al.
Published: (2015-01-01)

Cell therapy for spinal cord contusion injury: evaluation of the efficacy of cryopreserved human umbilical cord blood mononuclear cells in a preclinical model
by: S.I. Ryabov, et al.
Published: (2024-12-01)

CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01)

Dynamic Changes of Immunoreactive CD34, CD117, and CD41 Hematopoietic Stem Cells in Human Placentas of Different Gestational Ages
by: Sanja Jovicic, et al.
Published: (2025-05-01)

Editorial: Advancements in hematopoietic stem cell proliferation and self-renewal maintenance
by: Pawan Kumar Raghav, et al.
Published: (2025-07-01)

Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation
by: D. S. Dubnyak, et al.
Published: (2022-12-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

АВ0-INCOMPATIBILITY IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: 15-YEARS EXPERIENCE OF R.M. GORBACHEVA MEMORIAL RESEARCH INSTITUTE FOR CHILDREN ONCOLOGY, HEMATOLOGY AND TRANSPLANTATION
by: M. A. Kucher, et al.
Published: (2017-01-01)

Current status of hematopoietic stem cell transplantation in Russia
by: L. P. Mendeleeva, et al.
Published: (2022-11-01)

Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Molecular methods in identifying the true grouping of erythrocytes in patients with blood system diseases before transplantation of hematopoietic stem cells and their donors
by: L. L. Golovkina, et al.
Published: (2022-07-01)